BIOGEN INC.
Biotechnology company developing therapies for neurological and neurodegenerative diseases.
BIIB | US
Overview
Corporate Details
- ISIN(s):
- US09062X1037
- LEI:
- Country:
- United States of America
- Address:
- 225 BINNEY STREET, 2142 CAMBRIDGE
- Website:
- https://www.biogen.com/
- Sector:
- Manufacturing
Description
Biogen Inc. is a global biotechnology company focused on discovering, developing, and delivering innovative therapies for people with serious neurological and neurodegenerative diseases. Founded in 1978, the company leverages cutting-edge science to address complex and hard-to-treat conditions. Its core therapeutic areas include multiple sclerosis, Alzheimer's disease, spinal muscular atrophy, and amyotrophic lateral sclerosis. In addition to its portfolio of novel drugs, Biogen also develops and commercializes biosimilars. The company's pipeline is concentrated on potential breakthrough treatments in neurology, immunology, and rare diseases, aiming to address significant unmet medical needs and improve patient outcomes worldwide.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-02-03 08:04 |
8-K
|
English | 1.3 MB | ||
| 2021-01-29 17:47 |
PRIMARY DOCUMENT
|
English | 6.7 KB | ||
| 2021-01-29 17:45 |
PRIMARY DOCUMENT
|
English | 6.9 KB | ||
| 2021-01-29 17:44 |
PRIMARY DOCUMENT
|
English | 6.6 KB | ||
| 2021-01-29 17:43 |
PRIMARY DOCUMENT
|
English | 6.7 KB | ||
| 2021-01-29 17:41 |
PRIMARY DOCUMENT
|
English | 6.7 KB | ||
| 2021-01-28 18:56 | English | 13.7 KB | |||
| 2021-01-11 17:30 |
FORM 3 SUBMISSION
|
English | 6.7 KB | ||
| 2021-01-11 17:19 |
SC 13G
|
English | 14.4 KB | ||
| 2020-12-09 18:00 |
SC 13G/A
|
English | 15.5 KB | ||
| 2020-12-07 22:08 |
PRIMARY DOCUMENT
|
English | 7.7 KB | ||
| 2020-12-03 18:41 |
PRIMARY DOCUMENT
|
English | 7.6 KB | ||
| 2020-12-01 17:57 |
PRIMARY DOCUMENT
|
English | 6.6 KB | ||
| 2020-11-06 22:39 |
PRIMARY DOCUMENT
|
English | 6.7 KB | ||
| 2020-10-21 19:16 |
10-Q
|
English | 8.4 MB |
Automate Your Workflow. Get a real-time feed of all BIOGEN INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BIOGEN INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BIOGEN INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
